Streamline drug approval process

  • Echo Press | by: Peter J. Pitts |
  • 11/11/2018 12:00 AM
Streamline drug approval process
When you're desperately ill, your chances of recovery improve as your access to treatment improves. That's why it's such good news that the Food and Drug Administration is working to speed up the process of getting new medications to patients.

The FDA has two critical missions. One is to ensure that medications approved for sale to patients are safe and effective. The other is to get treatments to patients as quickly as possible.

Unfortunately, the two missions can come into conflict.

Approve a drug too quickly, without a comprehensive review of safety and efficacy, and the example that haunts all regulators might come to pass yet again. That would be the thalidomide tragedy of the 1950s, when a treatment for morning sickness in Great Britain in pregnant women led to severe birth defects.

But taking too long to approve a safe and effective treatment also takes a toll: patients who could benefit from the new treatment don't get it in a timely fashion, sometimes with fatal consequences.

 
Sign Up for Our Email Newsletter

RECENT NEWS

Waiving COVID-19 Vaccine Patents: A Bad Idea and a Dangerous Precedent

Waiving COVID-19 Vaccine Patents: A Bad Idea and a Dangerous Precedent

Waiving patent protection discourages cutting-edge research investments, which in turn produce breakthrough treatments no...  Read more

'I'm hopeful for the future': Alzheimer's drug approved by FDA

'I'm hopeful for the future': Alzheimer's drug approved by FDA

Peter Pitts of CMPI and Dr. Ronald Petersen of the Mayo Clinic discuss the FDA's approval of aducanumab...  Read more

Biosimilar Strength vs. Potency: Avoiding a Regulatory Hobson’s Choice

Biosimilar Strength vs. Potency: Avoiding a Regulatory Hobson’s Choice

Biosimilars bring lower costs and greater access to the market for biological products, but FDA must determine a predicta...  Read more

DRUGWONKS BLOG